UK markets closed

Axsome Therapeutics, Inc. (AXSM)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
74.74+0.55 (+0.74%)
As of 01:03PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close74.19
Open75.57
Bid74.59 x 100
Ask75.06 x 100
Day's range74.50 - 76.32
52-week range55.02 - 98.40
Volume333,513
Avg. volume720,716
Market cap3.55B
Beta (5Y monthly)1.10
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Zacks

    Should You Buy Axsome Therapeutics (AXSM) Ahead of Earnings?

    Axsome Therapeutics (AXSM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

  • Insider Monkey

    15 Most Black States in the US

    In this article, we will be taking a look at the 15 most black states in the US. If you do not want to learn about the demographics of global black population, head straight to the 5 Most Black States in the US. Overview of the Global Black Population: Demographics, Trends, and Immigration Patterns The […]

  • Zacks

    Axsome (AXSM) Begins Solriamfetol Binge Eating Phase III Study

    Axsome's (AXSM) phase III ENGAGE study is set to evaluate the efficacy and safety of solriamfetol for the treatment of binge eating disorder in adults.